Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer

Sheryl R. Krig, Seth Frietze, Catalina Simion, Jamie K. Miller, Will H D Fry, Hanine Rafidi, Lakmal Kotelawala, Lihong Qi, Obi L. Griffith, Joe W. Gray, Kermit L Carraway, Colleen A Sweeney

Research output: Contribution to journalArticle

44 Scopus citations

Fingerprint Dive into the research topics of 'Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences